Issuance of share subscription rights for directors
First written in FY2019-Q3. 12 of 14 entries say "Advanced", first in FY2019. Latest entry: 2026-07-17.
15 other companies' latest entry also says "Advanced".
- FY2026-H1AdvancedAnnual report
「Based on a resolution of the Board of Directors dated 12 June 2025, the Company disposed of 218,300 treasury shares on 11 July 2025 as restricted stock compensation, increasing other capital surplus by ¥3,711 thousand and reducing treasury shares by ¥45,188 thousand.」
Under its policy of discontinuing new stock option issuances for directors and transitioning to restricted stock compensation, the Company disposed of 218,300 treasury shares. - FY2025ReframedAnnual report
「Except for rights already granted, the Company will discontinue the stock option scheme for directors and will not issue any new stock acquisition rights as stock options for directors.」
The Company stated its policy of discontinuing new stock option issuances for directors and transitioning to a restricted stock compensation scheme. - FY2024-Q3AdvancedAnnual report
「Date of resolution 19 September 2023 Category and number of grantees (people) Directors of the Company, excluding non-executive directors: 4 Number of stock acquisition rights (rights)* 6,486 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 64,860 (Note 1) Exercise period of the stock acquisition rights* From 26 October 2023 to 25 October 2063」
The Company issued 6,486 Stock-Based Compensation Stock Acquisition Rights for 4 directors, covering 64,860 underlying shares. The exercise period is stated as 26 October 2023 to 25 October 2063, confirming the additional issuance. - FY2023AdvancedAnnual report
「Other (Transfers through exercise of stock options) 51,800」
The filing states that stock acquisition rights granted to directors in prior years were exercised for the equivalent of 51,800 shares. The 137,780 shares underlying the Fifth Stock Acquisition Rights remain as an undetermined balance. - FY2023-Q2AdvancedAnnual report
「Directors of the Company, excluding non-executive directors: 4 Number of stock acquisition rights (rights)* 13,778 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 137,780 Exercise period of the stock acquisition rights* From 20 July 2022 to 19 July 2062」
For the Fifth Stock-Based Compensation Stock Acquisition Rights, the Company issued 13,778 rights for 4 directors, covering 137,780 underlying shares, with an exercise period from 20 July 2022 to 19 July 2062. - FY2023-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 23 June 2022, the Company resolved to issue stock acquisition rights as stock options to its directors, excluding non-executive directors.」
The Company resolved to allocate 17,782 Fifth Stock-Based Compensation Stock Acquisition Rights to 4 directors, with 19 July 2022 as the allocation date. The filing states that the purpose is to strengthen the linkage with performance and the share price and increase directors' motivation to contribute to medium- and long-term earnings growth and enhancement of corporate value. - FY2022-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 24 August 2021, the Company resolved to issue stock acquisition rights as stock options to its directors, excluding outside directors, and issued them on 22 September 2021. Directors of the Company, excluding outside directors: 5 people, 3,810 rights」
The Company issued 3,810 Fourth Stock-Based Compensation Stock Acquisition Rights for 5 directors. The filing also states that the scheme is intended to strengthen the linkage with performance and the share price and increase directors' motivation to contribute to medium- and long-term earnings growth and enhancement of corporate value. - FY2021-Q3AdvancedAnnual report
「Date of resolution 18 September 2020 Category and number of grantees (people)* Directors of the Company, excluding outside directors: 5 Number of stock acquisition rights (rights)* 11,545 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 115,450 Exercise period of the stock acquisition rights* From 20 October 2020 to 19 October 2060」
For the Third Stock-Based Compensation Stock Acquisition Rights for 5 directors, the filing states the issuance of 11,545 rights covering 115,450 underlying shares and the exercise period, confirming the specific move from the previous resolution to issuance. - FY2021-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 18 September 2020, the Company resolved to issue stock acquisition rights as stock options to its directors, excluding outside directors. Third Stock-Based Compensation Stock Acquisition Rights of 株式会社リソー教育; 5 directors of the Company, excluding outside directors, 16,037 rights; allocation date: 19 October 2020.」
The Company resolved to issue 16,037 Third Stock-Based Compensation Stock Acquisition Rights for 5 directors, detailing progress on the additional stock-based compensation scheme. - FY2020-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 23 August 2019, the Company resolved to issue stock acquisition rights as stock options to its directors, excluding outside directors, and issued them on 24 September 2019. Directors of the Company, excluding outside directors: 8 people, 6,348 rights」
The Company issued 6,348 Second Stock-Based Compensation Stock Acquisition Rights for 8 directors on 24 September 2019. The filing describes the specific progress of this additional issuance following the previous scheme. - FY2019AdvancedAnnual report
「Regarding the First Stock-Based Compensation Stock Acquisition Rights of 株式会社リソー教育 granted during the fiscal year」
Details are provided for the First Stock-Based Compensation Stock Acquisition Rights for 8 directors, including 68,310 shares after the stock split and an exercise period from 20 November 2018 to 19 November 2058. - FY2019-Q3First statedAnnual report
「A holder of stock acquisition rights may exercise the rights only after losing both the position of director of the Company and the position of director of a subsidiary of the Company.」
During the third quarter of the current fiscal year, 2,277 stock acquisition rights, representing 22,770 underlying shares, were issued. The exercise period is stated as 20 November 2018 to 19 November 2058, and the exercise price is ¥1 per share.